Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression.
Martínez-Castelao
A
A
Nephrology Department, Hospital Príncipes de España, Bellvitge, CSUB, Hospitalet Llobregat, University of Barcelona, Barcelona, Spain. 9349amc@comb.es
Hueso
M
M
Sanz
V
V
Rejas
J
J
Sarrias
J
J
Alsina
J
J
Grinyó
J M
JM
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D003404:Creatinine / Q000097:blood; D018592:Cross-Over Studies; D016572:Cyclosporine / Q000627:therapeutic use*; D004311:Double-Blind Method; D017292:Doxazosin / Q000627:therapeutic use*; D004656:Enalapril / Q000627:therapeutic use*; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008055:Lipids / Q000097:blood; D008297:Male; D011183:Postoperative Complications / Q000188:drug therapy; D011507:Proteinuria; D014527:Uric Acid / Q000097:blood
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001786:Blood Glucose; D007166:Immunosuppressive Agents; D008055:Lipids; D014527:Uric Acid; D004656:Enalapril; D016572:Cyclosporine; D003404:Creatinine; D017292:Doxazosin